Cigna Corp (NYSE: CI) Q4 2020 earnings call dated Feb. 04, 2021.
Corporate Participants:
Alexis Jones — Lead Principal, Investor Relations
David Cordani — President and Chief Executive Officer
Brian Evanko — Chief Financial Officer
Analysts:
Gary Taylor — JPMorgan Chase & Co — Analyst
Kevin Fischbeck — Bank of America — Analyst
Matt Borsch — BMO Capital Markets — Analyst
Ralph Giacobbe — Citigroup Global Markets, Inc. — Analyst
Robert Jones — Goldman Sachs — Analyst
George Hill — Deutsche Bank — Analyst
A.J. Rice — Credit Suisse — Analyst
David Windley — Jefferies LLC — Analyst
Justin Lake — Wolfe Research — Analyst
Steven Valiquette — Barclays — Analyst
Joshua Raskin — Nephron Research LLC — Analyst
Charles Rhyee — Cowen — Analyst
Lance Wilkes — Bernstein — Analyst
Scott Fidel — Stephens Inc. — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results
DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line
Macy’s (M): A few points to consider if you have an eye on this retailer
Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit
Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent
Listen On
